Home / Science & Publications
Comment on: EULAR recommendations for the management of antiphospholipid syndrome in adults. Tektonidou MG, et al. Ann Rheum Dis. 2019;78:1296-1304. Commented by: Maria G. Tektonidou, MD, PhD, Associate Professor of Rheumatology. Head of Rheumatology Unit, First Department of Propaedeutic Internal Medicine, School of Medicine, University of Athens, Greece Due to the rarity of Antiphospholipid syndrome … Read more
Comment on: Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Dar E, et al. Nat Immunol. 2019;20:915-927. Commented by: Maria G. Tektonidou, MD, PhD, Associate Professor of Rheumatology. Head of Rheumatology Unit, First Department of Propaedeutic Internal Medicine, School of Medicine, University of Athens, Greece … Read more
Comment on: Petri M, Madger LS. Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus Cohort. Arthritis Rheum 2018; 1790– 1795 Commented by: Laurent Arnaud, Department of Rheumatology, National Reference Centre for Rare Systemic and Autoimmune Diseases East South-West (RESO), Strasbourg, France. Twitter: @Lupusreference. Email: Laurent.arnaud@chru-strasbourg.fr … Read more
Comment on: Fanouriakis A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 2019;78:736-45. Commented by: Nathalie Costedoat-Chalumeau, Internal Medicine Department, Cochin Hospital, Referral center for rare autoimmune and systemic diseases, Paris, France. The 2008 EULAR recommendations for the management of systemic lupus erythematosus (SLE) have … Read more
The objective and standardized estimation of disease activity has been always a necessity and, at the same time, a challenge in the manage of such a heterogeneous and complex disease as systemic lupus erythematosus (SLE). The use of a validated index has been recommended, not only for clinical research, but also for daily clinical care … Read more
Comment on: Aggarwal I, Li J, Trupin L, Gaynon L, Katz PP, Lanata C, Criswell L, Murphy LB, Dall’Era M, Yazdany J. Quality of Care for the Screening, Diagnosis, and Management of Lupus Nephritis Across Multiple Healthcare Settings. Arthritis Care Res (Hoboken) 2019 May 6. doi: 10.1002/acr.23915. [Epub ahead of print] Link: https://onlinelibrary.wiley.com/doi/abs/10.1002/acr.23915 Commented by: … Read more
Comment on: Tselios K, Gladman DD, Sheane BJ, Su J, Urowitz M. All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971-2013). Annals of the Rheumatic Diseases 2019; 78 (6): 802-806. Link: https://ard.bmj.com/content/78/6/802.long Commented by: Luís Inês, MD, PhD. Rheumatologist, CHUC Lupus Clinic, Rheumatology Dpt., … Read more
